Concepedia

Cesar Fisac

CF

Statistics

Publications

6

Citations

401

H-Index

6

Active since

2003

Affiliations

Bellvitge University Hospital(Current)

Vall d'Hebron Hospital Universitari

Hospital Clínic de Barcelona

Cesar Fisac is an author at Bellvitge University Hospital specializing in antiviral therapy, pharmacotherapy, and clinical pharmacology.

Publications per year

2003–2017

6

Publications

6

Less Lipoatrophy and Better Lipid Profile With Abacavir as Compared to Stavudine

Daniel Podzamczer, Elena Ferrer, Pochita Sanchez et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2006 · 137 citations

, , +17

Metabolic benefits 24 months after replacing a protease inhibitor with abacavir, efavirenz or nevirapine

Cesar Fisac, Emilio Fumero, Manuel Crespo et al. · AIDS · 2005 · 116 citations

, , +16

A Comparison of the Effects of Nevirapine and Nelfinavir on Metabolism and Body Habitus in Antiretroviral-Naive Human Immunodeficiency Virus-Infected Patients: A Randomized Controlled Study

Cesar Fisac, N. Virgili, Elena Ferrer et al. · The Journal of Clinical Endocrinology & Metabolism · 2003 · 72 citations · Full text

, , +17

Switching strategies to improve lipid profile and morphologic changes.

Patricia Barragán, Cesar Fisac, Daniel Podzamczer · PubMed · 2007 · 37 citations

, , +17

Clinical utility of the ASDAS index in comparison with BASDAI in patients with ankylosing spondylitis (Axis Study)

Xavier Roura, Alberto Alonso Ruiz, J. Rosas et al. · Rheumatology International · 2017 · 22 citations

, , +6

1–5 of 6